(Total Views: 784)
Posted On: 05/12/2020 4:07:34 PM
Post# of 155918
Re: Goosebumps #33600
I agree with you, and find that interview, that you mention very interesting. I think AGC would most certainly be speaking about Leronlimab.
It all ties in with everything that has been going on. NP & SK pumping money from shares, into the company, to fund production. The timeline of the trials, and FDA possibly waiting until CytoDyn has enough product in hand to supply the need, then they green light it.
Imagine if FDA green lighted it, before there is enough product to supply the need. It would cause chaos of who gets it, etc.
I think by end of June we will all be in a nice position, and we will see the impact of Leronlimab.
Just my thoughts.
It all ties in with everything that has been going on. NP & SK pumping money from shares, into the company, to fund production. The timeline of the trials, and FDA possibly waiting until CytoDyn has enough product in hand to supply the need, then they green light it.
Imagine if FDA green lighted it, before there is enough product to supply the need. It would cause chaos of who gets it, etc.
I think by end of June we will all be in a nice position, and we will see the impact of Leronlimab.
Just my thoughts.
(1)
(0)
